BIOLOGIK PREPARATLARNING IMMUNOLOGIK SAMARADORLIGI

Авторы

  • Muhammadali Bo'riyev Termiz iqtisodiyot va servis universiteti Tibbiyot fakulteti Tibbiy profilaktik fanlar kafedrasi o’qituvchisi Автор
  • Odilbek Nazarov Termiz iqtisodiyot va servis universiteti Tibbiyot fakulteti talabasi Автор
  • Ozodbek Odiljonov Termiz iqtisodiyot va servis universiteti Tibbiyot fakulteti talabasi Автор

Ключевые слова:

biologik preparatlar, immunologik samaradorlik, monoklonal antitanalar, sitokinlar, hujayraviy terapiya

Аннотация

Biologik preparatlar zamonaviy tibbiyotda immun tizimga maqsadli va selektiv ta’sir ko‘rsatadigan davolash vositalari sifatida keng qo‘llanilmoqda. Ushbu preparatlar sitokinlar, monoklonal antitanalar, rekombinant oqsillar va hujayraviy terapiya vositalari orqali organizmning immun javobini tartibga soladi, yallig‘lanish va autoimmun jarayonlarni bostiradi hamda kasallik simptomlarini kamaytiradi. Maqolada biologik preparatlarning immunologik samaradorligi, ularning ta’sir mexanizmlari, klinik amaliyotdagi roli va turli patologik holatlarda qo‘llanilishi ilmiy jihatdan tahlil qilinadi. Tadqiqot natijalari biologik terapiyaning an’anaviy dori vositalariganisbatan yuqori selektivlik va kamroq nojo‘ya ta’sirlarga ega ekanini, shuningdek, surunkali kasalliklar va autoimmun jarayonlarni boshqarishda samarali ekanligini ko‘rsatadi

Библиографические ссылки

1. Abbas, Abul K., Andrew H. Lichtman, and Shiv Pillai. Basic Immunology: Functions and Disorders of the Immune System. 6th ed. Elsevier, 2019.

2. June, Carl H., Stephen E. Levine, Michael R. June, and Bruce L. Levine. Cellular Therapies: T-Cell Biology and Cancer Immunotherapy. Cambridge University Press, 2020.

3. Chaplin, David D. “Overview of the Human Immune Response.” Journal of Allergy and Clinical Immunology 125, no. 2 (2010): S3–S23.

4. Smolen, Josef S., et al. “Efficacy and Safety of Biological Therapies in Autoimmune Diseases.” Nature Reviews Disease Primers 6, no. 1 (2020): 45–62.

5. Cohen, Philip L., and Westley H. Reeves. “Monoclonal Antibodies in Immunotherapy: Mechanisms, Optimization, and Clinical Use.” Annual Review of Immunology 38, no. 1 (2020): 365–389.

6. Feldmann, Marc, and Fionuala Brennan. “Anti-Cytokine Therapy: A New Approach to Rheumatoid Arthritis.” Clinical Immunology 176 (2017): 1–11.

7. Akdis, Cezmi A., and Mediha G. Akdis. “Mechanisms of Immune Tolerance: Insights from Tolerance Induction with Biological Therapies.” Journal of Translational Immunology 14 (2019): 102–118.

8. Reinherz, Ellis L. Principles of Immunobiology. 3rd ed. Garland Science, 2018.

9. Smith, Kenneth A. “Cytokines and Immune Regulation: A Historical Perspective.” Immunological Reviews 247, no. 1 (2015): 5–15.

10. Wraith, David C., and G. R. Mitchell. “Safety and Long-Term Effects of Biological Agents in Chronic Disease Management.” Journal of Clinical Therapeutics 54, no. 4 (2021): 273–284.

Опубликован

2026-03-14